Introduction – Addressing Core Industry Needs and Solutions
The global alternative protein landscape is undergoing a structural shift, driven by rising consumer demand for sustainable, low-carbon nutrition and the limitations of traditional plant-based and animal-derived proteins. Against this backdrop, mycoprotein food—derived from fungal biomass via precision fermentation—has emerged as a high-efficiency, neutral-taste, and scalable protein source. However, industry stakeholders face persistent challenges: inconsistent yields in fermentation technology, high production costs, and fragmented application pathways.
Global Leading Market Research Publisher QYResearch announces the release of its latest report *“Mycoprotein Food – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”*. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Mycoprotein Food market, including market size, share, demand, industry development status, and forecasts for the next few years.
The global market for Mycoprotein Food was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of % from 2026 to 2032.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/5986091/mycoprotein-food
1. Key Drivers and Technical Barriers in Mycoprotein Production
Unlike traditional plant-based proteins (soy, pea), mycoprotein offers complete amino acid profiles and high dietary fiber content. However, fermentation technology remains the core bottleneck. Submerged fermentation (SmF) and solid-state fermentation (SSF) dominate current industrial production, but contamination risks, oxygen transfer inefficiencies, and downstream processing costs limit scalability.
*Recent six-month data (Q3 2024–Q1 2025)*:
- At least three new pilot-scale fermentation facilities were announced in Europe and North America, focusing on Fusarium venenatum and Aspergillus oryzae strains.
- The average production cost of mycoprotein ingredients declined by ~12% year-over-year, driven by optimized fed-batch processes and cheaper carbon sources (e.g., food-grade starch hydrolysates).
2. Segmentation Deep-Dive: From Meat Alternatives to Dairy Analogs
The report segments the market by type and application, revealing distinct growth trajectories:
- By Type (Product Form):
- Meat Alternatives: Still the largest segment (>65% share in 2025), with burgers, nuggets, and minced formats leading.
- Seafood Alternatives: Emerging rapidly (+28% YoY in 2024), driven by mycoprotein-based shrimp and crab analogues.
- Yoghurt Dairy Products: Early-stage but high-potential, leveraging mycoprotein’s gelation properties for clean-label formulations.
- By Application:
- Supermarkets: Retail penetration increased by 34% in Western Europe, with private-label mycoprotein products gaining shelf space.
- Restaurant Chains: Quick-service restaurants (QSRs) like UK-based Leon and US-based Sweetgreen piloted mycoprotein menu items in 2024.
- Other (foodservice, e-commerce, B2B ingredients): Growing at CAGR 19% (2026–2032), led by Asia-Pacific markets.
3. Industry Vertical Differentiation: Discrete vs. Process Manufacturing in Mycoprotein Production
From an industrial operations perspective, mycoprotein manufacturing aligns more closely with process manufacturing (continuous fermentation, downstream purification, drying) than discrete assembly. This distinction is critical for capacity planning and quality control.
- Discrete manufacturing (e.g., plant-based burger patty assembly) focuses on component integration;
- Mycoprotein production requires real-time monitoring of pH, temperature, and dissolved oxygen, making it closer to biopharmaceutical processes.
This process intensity creates higher entry barriers but also allows for greater IP protection around proprietary strains and fermentation protocols.
4. User Case Studies and Regional Policy Impacts
Case 1 – Quorn (Monde Nissin):
As the market leader, Quorn expanded its UK manufacturing capacity by 40% in late 2024, focusing on chilled mycoprotein mince. However, supply chain disruptions in glucose feedstock (derived from wheat) led to a 6% price hike in Q1 2025, highlighting raw material vulnerability.
Case 2 – ENOUGH (Netherlands):
ENOUGH’s Abunda mycoprotein (derived from Fusarium strain) secured B Corp certification in January 2025, and partnered with a major European retailer to launch private-label mycoprotein strips. Their continuous fermentation system claims 95% lower land use than beef.
Policy Update:
- The EU’s Farm to Fork Strategy now explicitly lists fermented mycoprotein as a “priority alternative protein” for public procurement pilots (effective March 2025).
- Singapore Food Agency (SFA) approved two novel mycoprotein strains for sale in 2024, reinforcing its position as Asia’s regulatory sandbox for future foods.
5. Exclusive Industry Insight – The Unspoken Fragmentation Risk
While the market is poised for growth, a hidden risk lies in strain commoditization. Over a dozen startups now use similar Fusarium venenatum strains with marginal differentiation, potentially leading to price erosion. The real value creation will come from:
- Hybrid products (mycoprotein + mycelium + plant protein) for improved texture;
- Waste-stream upcycling (using brewery spent grain or citrus peel as fermentation feedstocks);
- Patent-protected downstream processing (e.g., flavor-blocking technologies for neutral-taste powders).
Market Outlook 2026–2032
The global mycoprotein food market is expected to grow at a CAGR of 12–18% across scenarios, with Asia-Pacific (led by China, Japan, and Singapore) becoming the fastest-growing region. Success will depend on securing low-cost, non-food-competing feedstocks and achieving price parity with chicken (currently ~$5–7/kg for mycoprotein vs. $4–6/kg for conventional chicken).
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
